SCHEMBL2724263

SCHEMBL2724263

O=C(O)c1cnc2cc(Br)ccc2c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.45
TSHR P16473 2/20 0.45
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
KDM4E B2RXH2 4/20 0.42
GLA P06280 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
RXFP1 Q9HBX9 2/20 0.42
NPC1 O15118 1/20 0.42
CSF1R P07333 1/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
THRB P10828 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX12 P18054 1/20 0.41
ATIC P31939 1/20 0.41
CES2 O00748 1/20 0.41
GALR3 O60755 1/20 0.41
BCL2L1 Q07817 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741418 0.87 HTT (0.55) HTTTSHRKDM4EGLAMEN1
SCHEMBL27903036 0.83 CA12 (0.44) HTTTSHRKDM4EMEN1KMT2A
SCHEMBL25311292 0.83 DHODH (0.43) HTTTSHREGFRERBB2KDM4E
SCHEMBL27920761 0.82 TSHR (0.56) HTTTSHREGFRERBB2KDM4E
Hydrochloric Acid SCHEMBL25311682 0.81 DHODH (0.42) HTTTSHREGFRERBB2KDM4E
SCHEMBL1617941 0.81 HSD17B10 (0.41) HTTTSHRKDM4EMEN1KMT2A
SCHEMBL1610495 0.81 CYP1A2 (0.49) HTTTSHREGFRKDM4EMEN1
SCHEMBL5767408 0.81 KEAP1 (0.42) HTTTSHRKDM4EMEN1KMT2A
SCHEMBL30592903 0.81 CYP1A2 (0.49) HTTTSHREGFRKDM4EMEN1
SCHEMBL5766222 0.81 ALDH1A1 (0.47) HTTTSHRKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103113298-A Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2013-05-22 CN claimed
CN-116478130-B N-hydroxyquinoline carboxamide compounds and uses thereof 深圳默元生物科技有限公司 2025-05-30 CN disclosed
WO-2023138674-A1 N-HYDROXYQUINOLINE CARBOXAMIDE COMPOUND AND USE THEREOF 默达药物(香港)有限公司 2023-07-27 WO disclosed
CN-116478130-A N-hydroxyquinoline carboxamide compounds and uses thereof 深圳默元生物科技有限公司 2023-07-25 CN disclosed
CN-103113298-B Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2014-12-31 CN disclosed
CN-103113298-B Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2014-12-31 CN disclosed
CN-103113298-B Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2014-12-31 CN disclosed
EP-2635279-A2 CHEMICAL COMPOUNDS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2013-09-11 EP disclosed
US-20130225524-A1 Chemical Compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2013-08-29 US disclosed
WO-2013096151-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2013-06-27 WO disclosed
CN-103113298-A Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2013-05-22 CN disclosed
CN-103113298-A Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2013-05-22 CN disclosed
CN-103113298-A Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid BEIJING GREENCHEM TECHNOLOGY CO LTD 2013-05-22 CN disclosed
WO-2012061557-A2 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2012-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225524-A1 Chemical Compounds LDHA, NQO2, LDHB HTT 3157/4885TSHR 3703/4885EGFR 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.